AU613154B2 - Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants - Google Patents
Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants Download PDFInfo
- Publication number
- AU613154B2 AU613154B2 AU30243/89A AU3024389A AU613154B2 AU 613154 B2 AU613154 B2 AU 613154B2 AU 30243/89 A AU30243/89 A AU 30243/89A AU 3024389 A AU3024389 A AU 3024389A AU 613154 B2 AU613154 B2 AU 613154B2
- Authority
- AU
- Australia
- Prior art keywords
- factor xiii
- intraventricular hemorrhage
- prevention
- premature infants
- hemorrhage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63-39646 | 1988-02-24 | ||
| JP63039646A JPH01216939A (ja) | 1988-02-24 | 1988-02-24 | 末熟児頭蓋内出血阻止剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3024389A AU3024389A (en) | 1989-08-24 |
| AU613154B2 true AU613154B2 (en) | 1991-07-25 |
Family
ID=12558846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU30243/89A Expired AU613154B2 (en) | 1988-02-24 | 1989-02-23 | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants |
Country Status (12)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612456A (en) * | 1988-11-14 | 1997-03-18 | Zymogenetics, Inc. | Factor XIII compositions |
| WO1993012813A1 (en) * | 1991-12-31 | 1993-07-08 | Zymogenetics, Inc. | Methods and compositions for reducing blood loss |
| EP0598133B1 (en) * | 1992-04-21 | 2000-03-29 | Ajinomoto Co., Inc. | Remedy for wound |
| ES2139729T3 (es) * | 1992-11-12 | 2000-02-16 | Zymogenetics Inc | Uso del factor xiii aplicado topicamente para la inhibicion de hemorragias. |
| JPH07328108A (ja) * | 1994-06-10 | 1995-12-19 | Ajinomoto Co Inc | 生体組織接着剤及び血液凝固剤 |
| CN1896231B (zh) | 1998-08-06 | 2012-09-05 | 山景药品公司 | 分离四聚体尿酸氧化酶的方法 |
| WO2006021584A2 (en) * | 2004-08-27 | 2006-03-02 | Novo Nordisk Health Care Ag | Purification of factor xiii polypeptides from biological materials |
| US8461302B2 (en) * | 2004-11-23 | 2013-06-11 | Zymogenetics, Inc. | Purification of recombinant human factor XIII |
| TWI418564B (zh) * | 2005-04-11 | 2013-12-11 | Savient Pharmaceuticals Inc | 利用陽離子界面活性劑之蛋白質純化 |
| EP2947145A1 (en) | 2005-04-11 | 2015-11-25 | Crealta Pharmaceuticals LLC | Variant forms of urate oxidase and use thereof |
| PL2013225T3 (pl) * | 2006-04-12 | 2015-06-30 | Crealta Pharmaceuticals Llc | Oczyszczanie białek z zastosowaniem kationowego środka powierzchniowo czynnego |
| US9377454B2 (en) | 2009-06-25 | 2016-06-28 | Crealta Pharmaceuticals Llc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
| US12121566B2 (en) | 2019-01-30 | 2024-10-22 | Horizon Therapeutics Usa, Inc. | Methods for treating gout |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7869487A (en) * | 1986-09-19 | 1988-03-31 | University Of Washington | Expression of biologically active factor XIII |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3717708A (en) * | 1968-10-24 | 1973-02-20 | Cutter Lab | Blood coagulation complex |
| DE2063070C3 (de) * | 1970-12-22 | 1975-07-24 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung |
| DE3622642A1 (de) * | 1986-07-05 | 1988-01-14 | Behringwerke Ag | Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung |
-
1988
- 1988-02-24 JP JP63039646A patent/JPH01216939A/ja active Granted
-
1989
- 1989-02-14 ES ES89102471T patent/ES2059588T3/es not_active Expired - Lifetime
- 1989-02-14 AT AT89102471T patent/ATE94070T1/de not_active IP Right Cessation
- 1989-02-14 EP EP89102471A patent/EP0330049B1/en not_active Expired - Lifetime
- 1989-02-14 DE DE89102471T patent/DE68908913T2/de not_active Expired - Lifetime
- 1989-02-23 AU AU30243/89A patent/AU613154B2/en not_active Expired
- 1989-02-23 IE IE58089A patent/IE63656B1/en not_active IP Right Cessation
- 1989-02-23 CA CA000591929A patent/CA1332352C/en not_active Expired - Lifetime
- 1989-02-23 KR KR1019890002127A patent/KR0137476B1/ko not_active Expired - Lifetime
- 1989-02-23 PT PT89802A patent/PT89802B/pt not_active IP Right Cessation
- 1989-02-23 DK DK198900838A patent/DK174978B1/da not_active IP Right Cessation
-
1990
- 1990-02-14 US US07/480,358 patent/US5114916A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7869487A (en) * | 1986-09-19 | 1988-03-31 | University Of Washington | Expression of biologically active factor XIII |
Also Published As
| Publication number | Publication date |
|---|---|
| PT89802A (pt) | 1989-10-04 |
| DE68908913D1 (de) | 1993-10-14 |
| DE68908913T2 (de) | 1994-01-27 |
| JPH01216939A (ja) | 1989-08-30 |
| PT89802B (pt) | 1994-04-29 |
| KR890012659A (ko) | 1989-09-18 |
| ATE94070T1 (de) | 1993-09-15 |
| DK174978B1 (da) | 2004-04-05 |
| KR0137476B1 (ko) | 1998-06-01 |
| US5114916A (en) | 1992-05-19 |
| DK83889A (da) | 1989-08-25 |
| IE63656B1 (en) | 1995-05-31 |
| AU3024389A (en) | 1989-08-24 |
| EP0330049A2 (en) | 1989-08-30 |
| EP0330049A3 (en) | 1991-01-30 |
| EP0330049B1 (en) | 1993-09-08 |
| DK83889D0 (da) | 1989-02-23 |
| IE890580L (en) | 1989-08-24 |
| CA1332352C (en) | 1994-10-11 |
| ES2059588T3 (es) | 1994-11-16 |
| JPH0378850B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1991-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU613154B2 (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
| Esmon | The regulation of natural anticoagulant pathways | |
| JPH02501028A (ja) | トロンビンから誘導されたポリペプチド、組成物およびその使用方法 | |
| DK167738B1 (da) | Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumfangsaktivitet af et protein med vaevs-plasminogenaktivator(t-pa)-aktivitet, oploesning der indeholder protein med t-pa-aktivitet, og anvendelsen af oploesningen inden for human- og veterinaermedicinen | |
| AU722743B2 (en) | Stabilized aqueous liquid preparations of blood coagulation factor XIII | |
| EP0278416B1 (en) | Use of human blood coagulation factor xiii for the treatment of ulcerative colitis | |
| Leimgruber et al. | Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy | |
| AT397615B (de) | Arzneimittel enthaltend protein c | |
| CA2091134C (en) | Therapeutic agent for threatened abortion | |
| US5164373A (en) | Therapeutic agent for diabetic gangrene comprising factor XIII | |
| AU674061B2 (en) | Factor XIII for treatment of skin wounds | |
| Tarter et al. | A clinical study of the use of intravenous urea in glaucoma | |
| RU2119316C1 (ru) | Способ лечения кровоизлияний во внутренние среды и оболочки глаза | |
| JP2698782B2 (ja) | 脳動脈瘤破裂防止剤 | |
| Pandolfi et al. | On intraocular fibrinolysis | |
| Nadal | Inhibition of hepatocyte proliferation in vivo by a glycopeptide from rat serum | |
| CA2159609C (en) | Factor xiii for treatment of skin wounds | |
| JOHNSON et al. | of a Factor VIII Concentrateđ | |
| JPH0495031A (ja) | 血栓溶解活性増強剤 | |
| JPH09176041A (ja) | α２プラスミンインヒビターを含有するＤＩＣ治療用薬剤 |